FP and EP2 prostanoid receptor agonist drugs and aqueous humor outflow devices for treating ocular hypertension and glaucoma.
第一作者:
Najam A,Sharif
第一单位:
Ophthalmology Innovation Center, Santen Inc., Emeryville, CA, USA; Singapore Eye Research Institute, Singapore; Eye-ACP Duke-National University of Singapore Medical School, Singapore; Department of Pharmacology and Neuroscience, University of North Texas Health Sciences Center, Fort Worth, TX, USA; Department of Pharmacy Sciences, Creighton University, Omaha, NE, USA; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX, USA; Imperial College of Science and Technology, St. Mary's Campus, London, UK; Institute of Ophthalmology, University College London, London, UK. Electronic address: najam.sharif@santen.com.
作者:
主题词
人类(Humans);眼房水(Aqueous Humor);青光眼(Glaucoma);高眼压(Ocular Hypertension);眼内压(Intraocular Pressure);抗高血压药(Antihypertensive Agents)
DOI
10.1016/j.exer.2023.109415
PMID
36803996
发布时间
2023-03-28
- 浏览2
Experimental eye research
109415页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文